By contrast, it has also been reported that ARB would have greater effects on VACM-1, U-8-OHdG, and PAI-1, while protecting organs, compared with calcium channel blockers in preclinical studies of diabetes. The gene discussed is SERPINE1; the disease is diabetes mellitus.